22nd Sep 2016 16:51
22 September 2016
Byotrol plc
("Byotrol" or the "Company")
Result of AGM
Byotrol plc, the developer of anti-microbial technologies, confirms that at its Annual General Meeting held earlier today, all resolutions were duly passed.
A copy of the presentation used at the AGM is available on the Company's website www.byotrol.co.uk.
Enquiries:
Byotrol plc | 01925 742 000 |
David Traynor - Chief Executive
| |
finnCap Ltd | 020 7220 0500 |
(Nominated Adviser & Broker) | |
Geoff Nash/Carl Holmes/James Thompson - Corporate Finance | |
Mia Gardner - Corporate Broking | |
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial technologies.Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens
Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.
For more information, please go to www.byotrol.co.uk
Related Shares:
BYOT.L